Thinking About Investing in Delek US (DK)? Know This!

Shares of Energy sector company Delek US moved -1.9% today, and are now trading at a price of $26.22. The small-cap stock's daily volume was 107,171 compared to its average volume of 1,290,706. The S&P 500 index returned a 0.2% performance.

Delek US Holdings, Inc. engages in the integrated downstream energy business in the United States. The company is based in Brentwood and has 3,312 full time employees. Its market capitalization is $1,827,332,224. Delek US currently offers its equity investors a dividend that yields 0.7% per year.

11 analysts are following Delek US and have set target prices ranging from $24 to $49 per share. On average, they have given the company a rating of hold. At today's prices, DK is trading -21.85% away from its average analyst target price of $33.55 per share.

Over the last year, DK's share price has increased by 71.7%, which represents a difference of 83.0% when compared to the S&P 500. The stock's 52 week high is $35.45 per share whereas its 52 week low is $14.71. Delek US has averaged free cash flows of $-88,200,000.0 over the last four years, with a mean growth rate of -181.7%. It is unlikely that the stock can sustain its current performance trend for the long term when the underlying business is experiencing such poor cash flows.

Date Reported Cash Flow from Operations ($ MM) Capital expenditures ($ MM) Free Cash Flow ($ MM) YoY Growth (%)
2021-12-31 371 -223 148 126.7
2020-12-31 -283 -272 -555 -490.09
2019-12-31 575 -433 142 n/a
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.